Zevra Therapeutics has won Food and Drug Administration approval of Miplyffa for Niemann-Pick disease type C, or NPC, making it the first drug cleared in the U.S. for the rare neurodegenerative ...
The completion of the Proposed Transaction is subject to the fulfilment, or waiver, of certain conditions, including board approvals, regulatory approvals, a satisfactory due diligence process, and ...
Recent testing from Consumer Reports and the FDA has found elevated levels of lead in cinnamon products and spice mixes. You ...
The snacks now have a Class I risk level, meaning there is a "reasonable probability" they could cause "serious adverse ...
The agency reviewed data from the MARIPOSA-2 trial and approved the regimen for patients with common EGFR mutations who are progressing on EGFR inhibitors.
Today, the U.S. Food and Drug Administration approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).
On to Plan B. House Republican leaders were unable to win passage Wednesday night of a stopgap spending bill that would have ...
The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...
Hence, this was an area where many ingredient and process suppliers at IFT First focused. “It is important for the flavor in ...
Weight-loss drugs like Ozempic are booming in popularity, but experts warn they aren't silver bullets for obesity.
The plaintiff, Skylar Williams, accused Galderma Laboratories of producing a skin-care line that contains benzene. In one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback